At2g35010 Antibody

Basic Research Questions

• How to validate the specificity of At2g35010 antibody in Arabidopsis experiments?

  • Perform immunoblotting with protein extracts from wild-type and At2g35010 knockout mutants. A single band at ~25 kDa (expected molecular weight) in wild-type samples, absent in knockouts, confirms specificity .

  • Use cross-reactivity assays with related peroxiredoxin family proteins (e.g., PrxIIF, Trx-o) to rule off-target binding. For example, mitochondrial purity can be confirmed by testing for cytosolic PrxII contamination using cytosolic-specific antibodies .

• What controls are essential for subcellular localization studies using this antibody?

  • Positive control: Isolated mitochondria treated with reducing agents (e.g., DTT) to validate antibody binding under redox-active conditions .

  • Negative control: Arabidopsis mitochondrial extracts pre-incubated with excess recombinant At2g35010 protein to block antibody binding .

• How to optimize antibody dilution for immunoprecipitation (IP)?

  • Test dilutions between 1:100 and 1:500 in IP buffer (e.g., 20 mM Tris-Cl, pH 8.0). Monitor co-precipitation of interacting partners (e.g., Trx-o) via SDS-PAGE and western blotting. Higher concentrations (1:100) improve yield but may increase non-specific binding .

Advanced Research Questions

• How to resolve conflicting data on At2g35010’s role in oxidative stress response?

  • Experimental design: Compare At2g35010 knockout vs. overexpression lines under controlled H2O2 exposure (0–10 mM). Measure peroxidase activity via NADH-coupled assays (e.g., Thurman et al., 1972 method) .

  • Data contradiction analysis: If activity discrepancies arise, check post-translational modifications (e.g., Cys59/Cys84 redox state) using non-reducing SDS-PAGE and mass spectrometry .

• What methods confirm structural interactions between At2g35010 and mitochondrial Trx-o?

  • Co-immunoprecipitation: Use anti-Trx-o antibodies to pull down complexes from mitochondrial lysates. Detect At2g35010 in precipitates via western blot .

  • Isothermal titration calorimetry (ITC): Measure binding affinity (Kd) between recombinant At2g35010 and Trx-o under varying redox conditions (e.g., 1–10 mM DTT) .

• How to model At2g35010-antibody binding dynamics for epitope mapping?

  • Epitope prediction: Use cryo-EM or X-ray crystallography of the antibody-antigen complex. Mutagenesis (e.g., alanine scanning at W406, K417) identifies critical binding residues, as seen in SARS-CoV-2 neutralizing antibody studies .

  • Computational tools: Apply diffusion probabilistic models (e.g., DiffAb) to simulate side-chain orientations and optimize binding free energy .

Methodological Notes

• Redox-dependent assays: Maintain mitochondrial extracts in 1–10 mM DTT during IP to preserve At2g35010’s oligomeric state .

• Antibody storage: Aliquot in glycerol-containing buffer (50% v/v) at -80°C to retain activity beyond 12 months .